EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access

Pharmacological Interventions for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Tourette Disorder: A Systematic Review and Network Meta-Analysis

Luis C Farhat iD, Emily Behling, Angeli Landeros-Weisenberger, Pedro Macul Ferreira de Barros, Guilherme V Polanczyk, Samuele Cortese, Michael H Bloch iD

Journal of Child and Adolescent Psychopharmacology · 2024

DOI: 10.1089/cap.2024.0049 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, 2024. Verfasst von Luis C Farhat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Tourette Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the comparative efficacy of pharmacological interventions for children and adolescents with a dual diagnosis of persistent tic disorders or Tourette disorder and attention-deficit/hyperactivity disorder (TD + ADHD).

Methods

We searched CENTRAL, Embase, PubMed, PsycInfo, Web of Sciences, ClinicalTrials.gov, and WHO ICTRP up to September 2023 to identify double-blinded randomized controlled trials (RCTs) assessing pharmacological interventions for children and adolescents with TD + ADHD. Outcomes were change in ADHD symptoms (primary) and tics (secondary) severity. Standardized mean difference (SMD) was calculated and pooled in random-effects network meta-analysis. The Confidence in Network Meta-Analysis framework was adopted to determine certainty of evidence.

Results

We included 8 RCTs involving 575 participants. Network meta-analyses demonstrated that α2 agonists (SMD, 95% confidence interval [CI] ADHD: −0.72 [−1.13 to −0.31]; TD: −0.70 [−0.96 to −0.45]) and stimulants + α2 agonists (ADHD: −0.84 [−1.54 to −0.13]; TD: −0.60 [−1.04 to −0.17]) were more efficacious than placebo for ADHD symptoms and tics severity. Stimulants alone were more efficacious than placebo for ADHD symptoms severity only, but they did not worsen tics (ADHD: −0.54 [−1.05 to −0.03]; TD: −0.22 [−0.49 to 0.05]). There were no significant differences between any pairs of medications that were found efficacious against placebo for ADHD symptoms or tics severity. Certainty in the evidence varied from low to very low.

Conclusions

Stimulants are efficacious for ADHD symptoms severity and do not increase tics severity in TD + ADHD. α2 agonists are efficacious for both ADHD symptoms and tics severity in TD + ADHD. These findings should inform guidelines and help guide shared decision-making to choose a medication for children with TD + ADHD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Attention Deficit Disorder with HyperactivityTourette SyndromeHumansChildAdolescentRandomized Controlled Trials as TopicAdrenergic alpha-2 Receptor AgonistsTic DisordersCentral Nervous System Stimulants

Stichwörter der Autor:innen

Tourette syndromeattention-deficit/hyperactivity disorderclinical trialsmethylphenidatenetwork meta-analysis

Substanzen

Adrenergic alpha-2 Receptor AgonistsCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Department of Psychiatry, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.
  • Child Study Center, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Centre for Innovation in Mental Health-Developmental Lab, School of Psychology, University of Southampton, Southampton, UK.
  • Solent NHS Trust, Southampton, UK.
  • Clinical and Experimental Sciences (CNS and Psychiatry), Faculty of Medicine, University of Southampton, Southampton, UK.
  • Hassenfeld Children's Hospital at NYU Langone, New York University Child Study Center, New York City, New York, USA.

ORCID-Profile: Luis C Farhat, Michael H Bloch

Förderung

  • NIMH NIH HHS

Zitieren

APA

Farhat, L. C., Behling, E., Landeros-Weisenberger, A., Macul Ferreira de Barros, P., Polanczyk, G. V., Cortese, S., & Bloch, M. H. (2024). Pharmacological Interventions for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Tourette Disorder: A Systematic Review and Network Meta-Analysis. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2024.0049

Vancouver

Farhat LC, Behling E, Landeros-Weisenberger A, Macul Ferreira de Barros P, Polanczyk GV, Cortese S, et al. Pharmacological Interventions for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Tourette Disorder: A Systematic Review and Network Meta-Analysis. Journal of Child and Adolescent Psychopharmacology. 2024. doi:10.1089/cap.2024.0049

BibTeX
@article{Farhat2024,
  author = {Farhat, Luis C and Behling, Emily and Landeros-Weisenberger, Angeli and Macul Ferreira de Barros, Pedro and Polanczyk, Guilherme V and Cortese, Samuele and Bloch, Michael H},
  title = {Pharmacological Interventions for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents with Tourette Disorder: A Systematic Review and Network Meta-Analysis},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2024},
  doi = {10.1089/cap.2024.0049}
}
Kostenlos starten →